Treatment of Early Glassy Cell Carcinoma of Uterine Cervix.
- Author:
Ok Bae KIM
1
;
Jin Hee KIM
;
Tae Jin CHOI
Author Information
1. Department of Radiation Oncology, Keimyung University School of Medicine, Daegu, Korea. obkim500@dsmc.or.kr
- Publication Type:Original Article
- Keywords:
Uterine cervical carcinoma;
Glassy cell carcinoma
- MeSH:
Biopsy;
Brachytherapy;
Cervix Uteri*;
Chemoradiotherapy;
Drug Therapy;
Female;
Follow-Up Studies;
Humans;
Hysterectomy;
Uterine Hemorrhage
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2006;24(2):123-127
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to investigate the clinical findings, treatment, and outcome of patients with glassy cell carcinoma of cervix. MATERIALS AND METHODS: We reviewed all cases of glassy cell carcinima of the uterine cervix confirmed and treated at the Dongsan Medical Center, Keimyung University, between January 1993 and December 2005. There were 7 cases with histopathologically confirmed gassy cell carcinoma. A tumor was diagnosed as glassy cell carcinoma if over 50% of the tumor cell type displayed glassy cell features. Six patients with stage IB had radical hysterectomy and bilateral pelvic node dissection, and 2 of them received adjuvant external pelvic irradiation with concurrent chemotherapy. Remaining one patient with stage IIA had curative concurrent chemoradiotherapy with external pelvic irradiation and brachytherapy. RESULTS: There were 7 patients diagnosed as glassy cell carcinoma among the 3,745 (0.2%) patients of carcinoma of uterine cervix. The mean age of 7 patients was 44 years with range of 35 to 53 years of age. The most frequent symptom was vaginal bleeding (86%). By the punch biopsy undertaken before treatment of 7 cases, 2 only cases could diagnose as glassy cell carcinoma of uterine cervix, but remaining of them confirmed by surgical pathological examination. The mean follow up duration was 73 months with range of 13 to 150 months. All 7 patients were alive without disease after treatment. CONCLUSION: Glassy cell carcinoma of the uterine cervix is a distinct clinicopathologic entity that demonstrates an aggressive biologic behavior. However for early-stage disease, we may have more favorable clinical outcome with radical surgery followed by chemoradiothery.
